Full-Time
Senior Quality Assurance Engineer
Updated on 9/3/2026
Konovo
Connects healthcare audiences with real-time insights
No salary listed
Bengaluru, Karnataka, India
Hybrid
Hybrid work environment; required on-site schedule is not specified.
 QA & Testing (1) |
|---|
Get referred to Konovo
See people who can refer or advise you
- At least 6 years of experience in software testing or quality engineering, including test automation and/or test architecture in product environments.
- Hands-on experience with UI and API automation, integration and database testing, performance testing, and building test frameworks.
- Experience with CI/CD quality engineering and observability, including tools such as Jenkins, GitHub Actions, and Grafana, plus familiarity with cloud platforms such as AWS, Azure, or Google Cloud Platform.
- Proficiency in Java, JavaScript, or a similar language, and modern automation tools such as Playwright, Cypress, K6, JMeter, Agentic AI, and MCP servers.
- Ability to apply and experiment with AI-enhanced engineering workflows with sound judgment and responsibility.
- Define and scale quality engineering standards, quality gates, and release-readiness frameworks across multiple squads.
- Architect end-to-end test strategy covering UI, API, database, integration, security, and performance testing.
- Drive shift-left quality practices across the software development life cycle and embed quality in pull requests and release cycles.
- Implement risk-based testing and prioritization to identify gaps early and focus effort on high-impact areas.
- Design, build, and scale enterprise automation frameworks and expand end-to-end automation for critical business workflows.
- Reduce manual regression through intelligent automation, improve stability, minimize flaky tests, and strengthen continuous integration and continuous delivery quality signals.
- Integrate artificial intelligence into quality engineering for test generation, defect classification, automated root-cause analysis, trend prediction, flaky-test detection, and release-health dashboards.
- Define performance benchmarks, identify bottlenecks across services, application programming interfaces, and data flows, and drive scalability, reliability, and response-time improvements.
- Establish continuous monitoring and observability standards and track pipeline health, failures, and release stability in real time.
- Own end-to-end quality assurance delivery across global teams, drive risks and blockers to closure, and provide executive-ready quality metrics, trends, and recommendations.
- Mentor and grow engineers through clear feedback and hands-on support.
- Strong ownership and clear cross-functional communication.
- Ability to operate effectively in ambiguous, global, fast-moving environments.
Konovo connects market research agencies and consultancies with healthcare professionals through a platform that provides real-time, tech-enabled data and insights. The platform-as-a-service gives clients direct access to engaged healthcare audiences, helping them quickly anticipate market trends and make informed business decisions. Konovo differentiates itself by focusing specifically on healthcare insights and delivering real-time access to credible professional audiences, tuned to broader business objectives. The company's goal is to be a leading platform in healthcare insights, enabling clients to access credible data and actionable intelligence to drive decision-making.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Watertown, Massachusetts
Founded
N/A
Get referred to Konovo
See people who can refer or advise you
Simplify's Take
What believers are saying
- Rare Patient Voice brought 200,000+ registered patients and caregivers across 1,500 diseases.
- Swathi Kulkarni and Tom Halliday joined January 6, 2026 to accelerate international sales.
- Konovo's March 2026 compliance hire supports regulated healthcare research and enterprise procurement.
What critics are saying
- Metaforms powers Survey Studio; Konovo's AI layer becomes replaceable inside twelve months.
- Litmys partnership on April 15, 2026 pushes higher-end insights into adjacent consultancies.
- Rare Patient Voice integration raises execution risk across thirteen countries and 200,000 patients.
What makes Konovo unique
- Konovo unifies patient, caregiver, and HCP access after Rare Patient Voice on February 3, 2026.
- Survey Studio, launched in 2025, compresses healthcare survey design from weeks to minutes.
- Jessica Santos joined March 3, 2026, adding compliance, AI governance, and privacy depth.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Hybrid Work Options
Remote Work Options
Wellness Program
Company News
Konovo, a healthcare intelligence company, has appointed Jessica Santos as Chief Compliance and Privacy Officer. Santos brings over 20 years of experience in healthcare compliance, AI governance and data privacy. Santos joins from Oracle Life Sciences, where she served as Global Compliance and Quality Director and Data Protection Officer, overseeing regulation, ethics and compliance across healthcare technologies. She previously held compliance leadership roles at Cerner, Kantar Health and Sermo, and was an associate professor at the University of Cambridge. At Konovo, Santos will integrate compliance, AI governance, legal, data privacy and IT risk into a unified operating model. She will also oversee pharmacovigilance and adverse event monitoring across global markets. Santos holds a PhD from Newcastle University and is a certified AI Governance Professional.
Rare Patient Voice joins Konovo. US - Healthcare intelligence company Konovo has acquired Rare Patient Voice, a panel recruitment company focused on patients and their families, for an undisclosed amount. The acquisition will support Konovo's work on patient-centric insights across therapeutic areas, in particular for rare and complex medical conditions. Rare Patient Voice was launched in 2013 and works across nine countries. Konovo will preserve Rare Patient Voice's approach while supporting it with platform infrastructure. Advertisement Tal Rosenberg, chief executive officer at Konovo, said acquiring Rare Patient Voice would help to bring together "authentic patient perspectives with physician insights" to support researchers. Wes Michael, founder and president of Rare Patient Voice, said: "The combination of RPV's community-centric approach and Konovo's platform scale creates new opportunities for researchers to engage patient and caregiver audiences more effectively."
Konovo, a healthcare intelligence company, has acquired Rare Patient Voice (RPV), a patient recruitment firm with over 200,000 registered patients and family caregivers across rare, chronic and complex conditions. The acquisition combines RPV's patient relationships with Konovo's technology platform and healthcare provider access. Founded in 2013, RPV operates across nine countries and covers more than 1,500 diseases. The deal enables researchers to access hard-to-reach patient populations whilst integrating patient and physician insights through a single platform. Konovo will use its infrastructure to expand RPV's reach whilst maintaining its community-focused approach. The company aims to accelerate high-quality insights from patients and healthcare professionals, particularly in rare and complex conditions where traditional recruitment methods often struggle.
Daily research news online. The global MR industry's daily paper since 2000. Senior hires strengthen global offer for Konovo. In Watertown, MA, USA, healthcare intelligence company Konovo has appointed two healthcare technology industry veterans, Swathi Kulkarni and Tom Halliday to its executive leadership team, with the respective titles of MD India and Chief Commercial Officer (CCO). Konovo was formed nine months ago from the merger of the three healthcare research firms within Apollo Intelligence - InCrowd, SHG and GlocalMind. The group operates across thirteen countries in the Americas, Europe and Asia, and is a portfolio company of Frazier Healthcare Partners. The company combines a global panel of healthcare professionals and patients with mobile-first quant and qual research capabilities, plus AI-based capabilities to streamline and integrate the gathering and sharing of insights. Last year the company added clinical research data veteran Gadi Lachman and former Kantar Health exec Jeremy Brody to its Board, and recently it launched a new suite called Survey Studio, allowing clients to rapidly design and script 'therapeutic-specific' healthcare surveys. Konovo says the two new hires will accelerate the expansion of its AI-native intelligent technology platform to meet the needs of all geographies. Kulkarni (pictured above) brings more than twenty years of experience building pioneering health tech companies and scaling them globally, most recently as CEO and co-founder of Elda Health, a full-stack digital wellness platform; and as Head of Health Management at Aditya Birla Health Insurance. Earlier she held executive leadership roles at Nua, a personal care product manufacturer; Inksedge, an events and communications company; and Komli Media, India's leading digital marketing platform. In her new role she will lead Konovo's India Innovation Hub, including strategy, P&L, growth delivery, talent and culture, and work to maximize the role that India plays in Konovo's success. Halliday (pictured below) also brings more than two decades of experience to bear on his new role, from life sciences roles on both the client and agency sides. Most recently, he was Strategic Intelligence General Manager at pharmaceutical solutions group Norstella, leading development of and strategy for the Strategic Intelligence business unit. Earlier he was CCO and Head of Real-World Data (RWD) at Clarivate Life Sciences, and held various leadership positions in Strategic Analytics and Competitive Intelligence at pharma and diagnostics giant Roche. In his new CCO role he will work to strengthen Konovo's senior-level partnerships and expand relationships across the global MR ecosystem. CEO Tal Rosenberg comments: 'Swathi and Tom are proven transformation agents whose deep life science technology expertise and relationships will help us introduce innovations to address longstanding market research industry challenges. With their strategic skills on our leadership team, Konovo can accelerate the expansion of our intelligent platform and help more healthcare and life science organizations worldwide to gain faster, more actionable insights that deliver value throughout their operations.' The company is on the web at www.konovo.com.
Konovo launches AI healthcare survey tool. US - Healthcare insight company Konovo has added a self-service platform for designing and scripting healthcare surveys. Konovo has formed a healthcare and life sciences partnership with AI market research platform Metaforms to integrate the latter's programming AI technology for the 'Survey Studio' tool. Through the tool, healthcare researchers can conduct surveys based on Konovo's life sciences insight base - around 15 years of healthcare research data, design standards and methodology. Advertisement The tool uses AI agents to bring together questionnaire design and survey programming. Konovo was formed in 2025 from the merger of healthcare research businesses InCrowd, SHG, and GlocalMind by owner Apollo Intelligence. The new survey tool will be available from the company in the fourth quarter of 2025. Tal Rosenberg, chief executive, Konovo, said: "We developed Survey Studio to give healthcare researchers an AI tool trained on healthcare intelligence, which can understand their context, governance requirements, and research needs, and help them build a field-ready survey in real time.